Intervention

cyclosporine

ClinicalTrials.gov intervention label

Clinical trials12

Recruiting0

Common conditions25

Lead sponsors shown10

Clinical trials

12 shown

Effects of Treatment With Biological Agents on Vascular and Cardiac Function in PsoriasisNCT02144857 · 2014-05-30

Diabetogenicity of Cyclosporine and TacrolimusNCT00766909 · 2008-03-01

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast CancerNCT00074269 · 2003-07-01

Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related LymphomaNCT00024128 · 2001-08-01

Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast CancerNCT00009763 · 2001-03-01

Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyNCT00009750 · 2001-03-01

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerNCT00365287 · 2000-06-01

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast CancerNCT00020176 · 2000-06-01

Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesNCT00006055 · 2000-03-01

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerNCT00112593 · 1999-11-01

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast CancerNCT00008203 · 1996-05-01

Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast CancerNCT00003920 · 1996-04-01

Common conditions

Breast Cancer6 Lymphoma2 Accelerated Phase Chronic Myelogenous Leukemia1 Acute Undifferentiated Leukemia1 Adult Acute Lymphoblastic Leukemia in Remission1 Adult Acute Myeloid Leukemia in Remission1 Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities1 Adult Acute Myeloid Leukemia With Del(5q)1 Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)1 Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)1 Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)1 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)1 Adult Grade III Lymphomatoid Granulomatosis1 Adult Nasal Type Extranodal NK/T-cell Lymphoma1 Aggressive NK-cell Leukemia1 AIDS-related Diffuse Large Cell Lymphoma1 AIDS-related Diffuse Mixed Cell Lymphoma1 AIDS-related Diffuse Small Cleaved Cell Lymphoma1 AIDS-related Immunoblastic Large Cell Lymphoma1 AIDS-related Lymphoblastic Lymphoma1 AIDS-related Peripheral/Systemic Lymphoma1 AIDS-related Primary CNS Lymphoma1 AIDS-related Small Noncleaved Cell Lymphoma1 Anaplastic Large Cell Lymphoma1 Anemia, Hemolytic, Autoimmune1

Leading sponsors

University of California, Davis3 AIDS Malignancy Consortium1 Fairview University Medical Center1 Fred Hutchinson Cancer Center1 Herbert Irving Comprehensive Cancer Center1 Masonic Cancer Center, University of Minnesota1 National Cancer Institute (NCI)1 University of Aarhus1 University of Athens1 University of California, San Diego1

Trial status mix

COMPLETED5

UNKNOWN5

TERMINATED1

WITHDRAWN1

Phase mix

PHASE14

PHASE24

NA2

PHASE42

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.